Search results
Results from the WOW.Com Content Network
A subsequent study of 495 women treated with DMPA over the course of 1 year found that the mean depression score slightly decreased in the whole group of continuing users from 7.4 to 6.7 (by 9.5%) and decreased in the quintile of that group with the highest depression scores at baseline from 15.4 to 9.5 (by 38%). [82]
The antidepressant known as bupropion ... eating a better diet, improving your exercise habits and maybe even getting a good night’s rest. ... Women in their 60s and 70s say this $27 eye cream ...
A 1992 World Health Organization report described normal human semen as having a volume of 2 mL or greater, pH of 7.2 to 8.0, sperm concentration of 20×10 6 spermatozoa/mL or more, sperm count of 40×10 6 spermatozoa per ejaculate or more, and motility of 50% or more with forward progression (categories a and b) of 25% or more with rapid ...
A 2006 review suggests that the widespread use of antidepressants in the new "SSRI-era" appears to have led to a highly significant decline in suicide rates in most countries with traditionally high baseline suicide rates. The decline is particularly striking for women who, compared with men, seek more help for depression.
One theory to explain antidepressant-related weight gain is that psychotropic medications such as antidepressants can affect neurotransmitters involved in eating behavior, causing an increase in ...
Lexapro is an antidepressant that can improve your mood and make symptoms of depression, anxiety, obsessive-compulsive disorder and other mental health issues less severe, helping you to focus on ...
Flibanserin is the first pharmaceutical product from Sprout Pharmaceuticals [14] for premenopausal women with HSDD. The drug was approved by the FDA in 2015. It compiles a serotonin 1A receptor agonist and a serotonin 2A receptor antagonist. [15] and is an antidepressant [16] that was originally developed for depression. [12]
Use of antidepressants during pregnancy may result in fetus abnormalities affecting functional development of the brain and behavior. [90] Studies have shown correlations between pregnant women treated with SNRIs and risk of hypertensive disorders, [91] preeclampsia, [92] miscarriage, [93] seizures in children, [94] and many other adverse affects.